Cryosite (ASX: CTE) — Company Overview, News & Financial Data
Cryosite is a specialist provider of biological material management, clinical trial logistics, and cord blood and tissue banking services based in Australia.
Cryosite
Cryosite is a specialist provider of biological material management, clinical trial logistics, and cord blood and tissue banking services based in Australia. The company offers specialized cold-chain logistics, temperature-sensitive storage, and distribution services for commercial companies, clinical research organizations, and academic institutions participating in medical trials. Additionally, Cryosite operates licensed cord blood and umbilical cord tissue storage facilities, maintaining preserved stem cell samples for family healthcare use. Its infrastructure includes cryopreservation, biorepository management, and specialized bio-storage facilities equipped to handle temperature ranges from ambient down to liquid nitrogen vapor phase across cryogenic biological inventory management.
Snapshot
Operations
Products and/or services of Cryosite
- Clinical Trial Logistics: Temperature-controlled distribution, depot services, and regulatory compliant transport management for investigational medicinal products, medical devices, and biological samples supporting pharmaceutical and clinical research organizations across domestic and international research sites.
- Biological Material Storage: Cryogenic and ultra-low temperature bio-repository services providing managed storage solutions for bio-banks, pharmaceutical assets, cellular therapies, and tissue samples utilizing liquid nitrogen, deep-freeze, and ambient controlled environment infrastructure.
- Cord Blood Banking: Collection, processing, cryopreservation, and long-term storage of umbilical cord blood stem cells for newborn families, providing potential future regenerative medicine and cellular therapy applications under strict regulatory compliance.
- Cord Tissue Banking: Specialized processing and cryopreservation of umbilical cord tissue, securing mesenchymal stem cells for potential therapeutic applications in regenerative medicine and clinical treatments through accredited bio-containment storage infrastructure.
- Cell Therapy Logistics: Specialized cold-chain storage and supply chain management for cellular therapies, gene therapies, and advanced therapy medicinal products requiring continuous cryogenic monitoring and rapid point-of-care delivery schedules.
- Bio-Repository Management: Comprehensive biological sample archiving, inventory cataloging, destruction management, and audit-ready data tracking services tailored for biotechnology companies, research institutes, and healthcare organizations operating long-term biological studies.
Cryosite executive team
- Ms. Jane HaoChief Financial Officer
- Ms. Alicia SteelChief Quality Officer
- Mr. Andrew KerrExecutive Director
- Mr. Jon StearnsOperations Manager
- Mr. Hamish GeorgeCompany Secretary